drugset / Trial / NCT01506934

A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

NCT01506934

Phase 1 Terminated 14 enrolled Abbott
RandomizedCrossoverOpen-labelBasic science

Summary

A pharmacokinetic study to compare 2 clinical formulations of linifanib and the effect of food on the pharmacokinetics of linifanib.

Timeline

Start
2011-10
Primary completion
2011-12
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-869 Unknown

Indications

No indication recorded.